CP and fungal infectious disease: The observed slow fungal growth phenotype on plates was associated with a significantly lower level of oxalic acid production, which is an essential factor for fungal infection [18], from mycelium 48 hours following SsHADV1-REP treatment (P < 0.01), when compared to the SsHADV1-CP-treated or EV-treated S. sclerotiorum (Fig 7A).